US3723032062
Impact Score
Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer and other serious diseases.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
3 548 | DKK million | 2023 | Genmab 2023 Annual Report.pdf | 87 | ||
2 011 | employees | 2023 | Genmab 2023 Annual Report.pdf | 10 | ||
44,3 | DKK million | 2023 | Genmab 2023 Annual Report.pdf | 111 | ||
Jan G. J. van de Winkel | 2023 | 0001558370-24-001137.pdf | 87 | |||
Employee turnover rate | ||||||
6 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 | ||
Glass Ceiling | ||||||
58 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 | ||
52 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 | ||
Greenhouse Gas Emissions | ||||||
317 | tCO2e | 2023 | Corporate Responsibility Report 2023.pdf | 37 | ||
238 | tCO2e | 2023 | Corporate Responsibility Report 2023.pdf | 37 | ||
2 011 | employees | 2023 | Genmab 2023 Annual Report.pdf | 10 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | Corporate Responsibility Report 2023.pdf | 32 | |||
Yes | 2023 | Corporate Responsibility Report 2023.pdf | 32 | |||
Yes | 2023 | Human Rights Commitment FINAL.pdf | 1 | |||
Yes | 2023 | Human Rights Commitment FINAL.pdf | 1 | |||
Renewable Energy | ||||||
83 | % | 2023 | Corporate Responsibility Report 2023.pdf | 37 | ||
Union Formation and Collective Bargaining Power | ||||||
0 | % | 2023 | 0001558370-24-001137.pdf | 96 | ||
Women on the Board | ||||||
2 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
9 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
2 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
0 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
Women in Management | ||||||
52 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 |